SS Innovations International Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, receiving recognition for its work in developing and commercializing robotic surgery technology (https://nnw.fm/mXdgs). The company was selected over nine other finalists, including established medical technology companies such as Intuitive, Johnson & Johnson MedTech, and Medtronic.
The Surgical Robotics Industry Awards recognize one company each year in the Outstanding Company category based on criteria including commercial performance, technological innovation, societal impact, customer recognition, ethical standards, and workplace practices. Chairman and CEO Dr. Sudhir Srivastava said the award reflects the company's focus on expanding access to robotic surgery while developing technologies to improve affordability.
The recognition coincides with continued operational growth for the company's flagship SSi Mantra surgical robotic platform. As of June 22, 2026, surgeons had completed a cumulative 11,719 multi-specialty procedures using the SSi Mantra system, including 612 cardiac surgeries, 175 telesurgeries, and 212 pediatric operations. Physicians have used the platform in more than 170 different types of surgical procedures.
Training has also expanded alongside system adoption. Approximately 2,100 physicians have completed training on the SSi Mantra platform, an important factor for surgical robotics systems where physician education influences hospital purchasing decisions and long-term utilization.
The company's commercial footprint has continued to broaden internationally. Regulatory approvals have been granted in 14 countries: Colombia, Ecuador, Guatemala, Guyana, India, Indonesia, Iraq, Kenya, Nepal, Oman, the Philippines, Sri Lanka, Ukraine, and the United Arab Emirates. These approvals provide opportunities for continued market expansion as healthcare systems evaluate robotic-assisted surgery.
SS Innovations describes the SSi Mantra as a modular, multi-arm robotic surgery platform designed to support multiple surgical specialties. The system incorporates three to five robotic arms, a three-dimensional 4K visualization system, an ergonomic surgeon console, and digital imaging capabilities. Its instrument portfolio includes more than 40 robotic surgical instruments, including smaller 5-millimeter instruments for pediatric and ear, nose, and throat procedures. The company has also developed a portable tele-surgeon console, the SSi MantrAsana, which supports remote surgical capabilities.
For investors, the award provides an independent industry endorsement as SS Innovations continues to expand its presence in the rapidly growing global surgical robotics market. For more information, visit the company's website at www.SSInnovations.com.
